Tweets by SSO 2024 Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Recorded for On-Demand Viewing

Type here to filter the list

Thursday, Mar 21st
9:30am – 10:30am ET
Next Generation Sequencing in Hepatobiliary Cancers
Location: C102
Moderator: Jen Jen Yeh, MD – University of North Carolina at Chapel Hill
Moderator: Rohit Chandwani, MD, PhD (he/him/his) – Weill Cornell Medical College
HPBCME
Thursday, Mar 21st
12:30pm – 1:00pm ET
Safely Developing Your HPB Practice: Lessons from Early Career Surgeons in Both Academic and Community-Based Programs
Location: SSO HUB: HPB, CRS, Upper GI Zone
HUB Moderator: Chee-Chee Stucky, MD – Mayo Clinic Arizona
HPBnon-CMEHUB
Thursday, Mar 21st
2:00pm – 3:30pm ET
HPB Parallel Session 1
Location: C101
Moderator: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
Moderator: Laleh Melstrom, MD – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA
HPBCMEOral Abstracts
Thursday, Mar 21st
2:02pm – 2:12pm ET
42: Salvage Hepatic Artery Infusion Chemotherapy after First Line Systemic Failure in Patients with Unresectable Cholangiocarcinoma
Location: C101
Abstract Presenter: Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine
Submitter: Misha Armstrong, MD MPH (she/her/hers) – New York Presbyterian / Weill Cornell Medicine
Author: Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Joanne Chou, MS – Memorial Sloan Kettering Cancer Center
Author: Mithat Gonen, PhD – Memorial Sloan Kettering Cancer Center
Author: Kevin C. C. Soares, MD – Memorial Sloan Kettering Cancer Center
Author: Vinod P. Balachandran, MD – Memorial Sloan Kettering Cancer Center
Author: Jeffrey A. Drebin, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center
Author: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Michael I. I. D'Angelica, MD – Memorial Sloan Kettering Cancer Center
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
Author: James J. J. Harding, MD – Memorial Sloan Kettering Cancer Center
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
Author: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
Author: Wungki Park, MD – Memorial Sloan Kettering Cancer Center
Author: Louise Connell, MD – Memorial Sloan Kettering Cancer Center
Author: Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center
Author: William R. R. Jarnagin, MD – Memorial Sloan Kettering Cancer Center
HPB
Thursday, Mar 21st
2:12pm – 2:22pm ET
43: An Update On The Phase I Study to Evaluate the Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma
Location: C101
Abstract Presenter: Nicholas A. Ullman, MD – University of Rochester Medical Center
Submitter: Nicholas A. Ullman, MD – University of Rochester Medical Center
Author: Nicholas A. Ullman, MD – University of Rochester Medical Center
Author: Richard Dunne, MD – University of Rochester
Author: Daniel Mulkerin, MD – University of Rochester
Author: Brian Belt, JD – University of Rochester
Author: Luis I. Ruffolo, MD – University of Rochester
Author: Paul R. Burchard, MD – University of Rochester
Author: Matthew Byrne, MD – University of Rochester Medical Center
Author: Mary Georger, MS – University of Rochester
Author: Aram Hezel, MD – University of Rochester
Author: Jason Zittel, MD – University of Rochester
Author: Wenjia Wang, MD – University of Rochester
Author: Erika Ramsdale, MD – University of Rochester
Author: Vivek Kaul, MD – University of Rochester
Author: John Zebala, MD – Syntrix Pharmaceuticals
Author: David Linehan, MD – University of Rochester Medical Center
HPB
Thursday, Mar 21st
2:22pm – 2:32pm ET
44: Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)
Location: C101
Abstract Presenter: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Submitter: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Ujwal R. Yanala, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Mary Martos, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine
Author: Andres Corona, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Nkiruka Ezenwajiaku, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Joseph Pizzolato, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Gretel Terrero, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Caitlin A. Hester, MD – Division of Surgical Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Cente
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
Author: Peter Hosein, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
HPB
Thursday, Mar 21st
2:32pm – 2:42pm ET
45: Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)
Location: C101
Abstract Presenter: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Submitter: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Tyler J. Zemla, MS – Alliance Statistics and Data Management Center
Author: Qian Shi, PhD – Alliance Statistics and Data Management Center
Author: Diana Segovia, BS – Alliance Statistics and Data Management Center
Author: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
Author: Joseph M. Herman, MD – Northwell Health Cancer Institute
Author: Matthew H.G Katz, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
HPB
Thursday, Mar 21st
2:42pm – 2:52pm ET
46: A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency
Location: C101
Abstract Presenter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Submitter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Author: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Author: Karthik Rajkumar, PhD – University of Miami
Author: Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL
Author: Lucas Caeiro, PhD – University of Miami School of Medicine - Miami, FL
Author: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
Author: Luis Nivelo, MS – University of Miami School of Medicine - Miami, FL
Author: Iago De Castro Silva, MD – University of South Florida
Author: Andrew Adam, MS – University of Miami School of Medicine - Miami, FL
Author: Vanessa Garrido, PhD – University of Miami School of Medicine - Miami, FL
Author: Samara Singh, BS – University of Miami School of Medicine - Miami, FL
Author: Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
Author: Ramiro Verdun, PhD – University of Miami School of Medicine - Miami, FL
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
HPB
Thursday, Mar 21st
2:52pm – 3:02pm ET
47: Chemotherapy Dose Density is Prognostic for Patients with Resectable Pancreas Cancer: A Secondary Analysis of SWOG S1505
Location: C101
Abstract Presenter: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
Submitter: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
Author: Sameer H. Patel, MD, FSSO (he/him/his) – Division of Surgical Oncology, University of Cincinnati, Cincinnati, OH, United States
Author: Sarah Colby, PhD – Fred Hutchinson Cancer Center
Author: Davendra Sohal, MD – University of Cincinnati College of Medicine
Author: Katherine Guthrie, PhD – Fred Hutchinson Cancer Center
Author: Lisa Kachnic, MD – Columbia University Irving Medical Center
Author: Gabriela Chiorean, MD – University of Washington
Author: Andrew M. Lowy, MD – Department of Surgery, Division of Surgical Oncology, University of California, San Diego
Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Philip Philip, MD – Wayne State University Henry Ford Cancer Institute
Author: Syed A. Ahmad, MD (he/him/his) – University of Cincinnati Cancer Center
HPB
Thursday, Mar 21st
3:02pm – 3:12pm ET
48: Highly Sensitive Low Input Methylated Digital Droplet PCR Assay for Pancreatic Adenocarcinoma Molecular Subtyping
Location: C101
Abstract Presenter: Hannah Trembath, MD – University of North Carolina
Submitter: Hannah Trembath, MD – University of North Carolina
Author: Hannah Trembath, MD – University of North Carolina
Author: Ian McCabe, B.S. – University of North Carolina at Chapel Hill
Author: Sandra Zarmer, B.S. – University of North Carolina at Chapel Hill
Author: Zachary Schrank, B.S. – University of North Carolina at Chapel Hill
Author: Hannah Thel, B.S. – University of North Carolina at Chapel Hill
Author: Justin Ashby, B.S. – University of North Carolina at Chapel Hill
Author: Joseph Kearney, M.D. – UNC Hospitals- General Surgery
Author: Yi Xu, B.S. – University of North Carolina at Chapel Hill
Author: Gabriela Herrera, B.S. – University of North Carolina at Chapel Hill
Author: Des Weighill, Ph.D. – University of North Carolina at Chapel Hill
Author: Jen Jen Yeh, MD – University of North Carolina at Chapel Hill
HPB
Thursday, Mar 21st
3:12pm – 3:22pm ET
49: A Prospective Evaluation of a Modified Hepatic Arterial Infusion Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases
Location: C101
Abstract Presenter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Submitter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
Author: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Adel Kardosh, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Jillian Paxton, PharmD – OHSU, Department of Pharmacy Services, Portland, OR 97239 USA
Author: Robert Eil, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Emerson Chen, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA
Author: Guillaume Pegna, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
Author: Charles Lopez, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
HPB
Thursday, Mar 21st
3:35pm – 4:20pm ET
HPB Great Debate: Chasing Intraoperative Margins During Pancreatoduodenectomy – Always or Never?
Location: C101
Moderator: Julie Hallet, MD MSc FRCSC FSSO (she/her/hers) – Department of Surgery, Division of General Surgery, University of Toronto
HPBCME
Friday, Mar 22nd
11:30am – 12:00pm ET
HPB Poster Presentations 1
Location: C110
Poster Session Moderator: William R. Burns, MD – Johns Hopkins Department of Surgery
Poster Session Moderator: Ryan M. Thomas, MD – University of Florida
HPBnon-CME
Friday, Mar 22nd
11:31am – 11:37am ET
P30: Aryl Hydrocarbon Receptor Ligands Found in Cigarette Smoke Drive Pancreatic Cancer Via Pro-Tumorigenic T Cell Polarization
Location: C110
Oral Poster Presenter: Brian D. Griffith, MD (he/him/his) – Department of Surgery, University of Michigan
Submitter: Brian D. Griffith, MD (he/him/his) – Department of Surgery, University of Michigan
Author: Brian D. Griffith, MD (he/him/his) – Department of Surgery, University of Michigan
Author: Padma Kadiyala, BS – Department of Immunology, University of Michigan
Author: Jake McGue, BS – Department of Surgery, University of Michigan
Author: Lei Sun, PhD – Department of Surgery, University of Michigan
Author: Aadith Kumar, n/a – Department of Surgery, University of Michigan
Author: Carlos Espinoza, MS – Department of Surgery, University of Michigan
Author: Jacob Edwards, BS – Department of Surgery, University of Michigan
Author: Katelyn Donahue, BS – Cancer Biology Program, University of Michigan
Author: Yaqing Zhang, PhD – Department of Surgery, University of Michigan
Author: Clifford S. Cho, MD – Department of Surgery, University of Michigan
Author: Marina Pasca di Magliano, PhD – Departments of Surgery and Cell Biology, University of Michigan
Author: Timothy L. Frankel, MD, FACS – Department of Surgery, University of Michigan; Department of Surgery, Ann Arbor Veterans Affairs Healthcare System
HPB
Friday, Mar 22nd
11:37am – 11:43am ET
P31: Survival of Patients with Microsatellite Instability-High and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas
Location: C110
Oral Poster Presenter: Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Submitter: Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Naaz Nasar, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Ellis L. Eikenboom, PhD candidate – Erasmus University Medical Center
Author: Kenneth Seier, MS – Memorial Sloan Kettering
Author: Mithat Gonen, PhD – Memorial Sloan Kettering Cancer Center
Author: Anja Wagner, PhD – Erasmus University Medical Center
Author: William R. R. Jarnagin, MD – Memorial Sloan Kettering Cancer Center
Author: Jeffrey A. Drebin, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: Michael I. I. D'Angelica, MD – Memorial Sloan Kettering Cancer Center
Author: T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center
Author: Vinod P. Balachandran, MD – Memorial Sloan Kettering Cancer Center
Author: Kevin C. C. Soares, MD – Memorial Sloan Kettering Cancer Center
Author: Manon C.W. Spander, MD PhD – Erasmus University Medical Center
Author: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center
HPB
Friday, Mar 22nd
11:43am – 11:49am ET
P32: JNK inhibition reprograms the tumor-immune-microenvironment to overcome chemoresistance in PDAC
Location: C110
Oral Poster Presenter: Edmond W. Box, III, MD – UM
Submitter: Edmond W. Box, III, MD – UM
Author: Edmond W. Box, III, MD – UM
Author: Samara Singh, BS – University of Miami School of Medicine - Miami, FL
Author: Vanessa Tonin Garrido, Ph.D. – UM
Author: Siddharth Mehra, Ph.D. – UM
Author: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
Author: Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine
Author: Mary Martos, MD – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center.
Author: Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
HPB
Friday, Mar 22nd
11:49am – 11:55am ET
P33: The Role of Human Adipocytes Derived Extracellular Vesicles in Mediating Pancreatic Cancer Growth and Angiogenesis
Location: C110
Author: Donia Seh, n/a – Tel-Aviv Soursky Medical Center
Oral Poster Presenter: Shelly Loewenstein (she/her/hers) – Surgery Division, Tel Aviv Sourasky medical center
Submitter: Shelly Loewenstein (she/her/hers) – Surgery Division, Tel Aviv Sourasky medical center
Author: Shelly Loewenstein (she/her/hers) – Surgery Division, Tel Aviv Sourasky medical center
Author: Sapir Milshtain, n/a – Tel Aviv Sourasky Medical Center
Author: Guy Lahat, n/a (he/him/his) – Tel-Aviv Sourasky Medical Center
HPB
Friday, Mar 22nd
1:45pm – 2:15pm ET
HPB Poster Presentations 2
Location: C110
Poster Session Moderator: Sandra DiBrito, MD PhD (she/her/hers) – Albany Medical College
Moderator: John Mansour, MD – University of Texas Southwestern
HPBnon-CME
Friday, Mar 22nd
1:46pm – 1:52pm ET
P34: Utilization of Deep Learning Algorithms for Predicting Positive Portal/Superior Mesenteric Vein Margin in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
Location: C110
Oral Poster Presenter: Amr I. Al Abbas, MD (he/him/his) – UT Southwestern Medical Center
Submitter: Amr I. Al Abbas, MD (he/him/his) – UT Southwestern Medical Center
Author: Amr I. Al Abbas, MD (he/him/his) – UT Southwestern Medical Center
Author: Andres A. Abreu, MD (he/him/his) – Department of Surgery, University of Texas Southwestern Medical Center
Author: shekharmadhav khairnar, MS – UT Southwestern Medical Center
Author: Jae Pil Jung, MD – UPMC
Author: Patricio M. Polanco, MD – Department of Surgery, University of Texas Southwestern Medical Center
Author: Melissa Hogg, MD MS (she/her/hers) – Department of Surgery, NorthShore University HealthSystem
Author: Amer H. Zureikat, MD – Division of Surgical Oncology, University of Pittsburgh Medical Center
Author: Matthew R. Porembka, MD (he/him/his) – University of Texas Southwestern Medical Center
Author: Herbert J. Zeh, III, MD – Department of Surgery, University of Texas Southwestern Medical Center
Author: Ganesh sankaranarayanan, PhD – UT Southwestern Medical Center
HPB
Friday, Mar 22nd
1:52pm – 1:58pm ET
P35: Extrahepatic Cholangiocarcinoma: Genomic Variables Associated with Anatomical Location and Outcome
Location: C110
Oral Poster Presenter: William A. Preston, MD – Memorial Sloan Kettering Cancer Center
Submitter: William A. Preston, MD – Memorial Sloan Kettering Cancer Center
Author: William A. Preston, MD – Memorial Sloan Kettering Cancer Center
Author: Esther Drill, DrPH – Memorial Sloan Kettering Cancer Center
Author: Thomas Boerner, MD – Memorial Sloan Kettering Cancer Center
Author: James J. J. Harding, MD – Memorial Sloan Kettering Cancer Center
Author: Eileen M. O'Reilly, MD – Memorial Sloan Kettering Cancer Center
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
Author: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
Author: Vinod P. Balachandran, MD – Memorial Sloan Kettering Cancer Center
Author: Jeffrey A. Drebin, MD, PhD – Memorial Sloan Kettering Cancer Center
Author: Wungki Park, MD – Memorial Sloan Kettering Cancer Center
Author: Kevin C. C. Soares, MD – Memorial Sloan Kettering Cancer Center
Author: Alice C. Wei, MD, MS, FRCSC (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: T. Peter Kingham, MD – Memorial Sloan Kettering Cancer Center
Author: Michael I. I. D'Angelica, MD – Memorial Sloan Kettering Cancer Center
Author: William R. R. Jarnagin, MD – Memorial Sloan Kettering Cancer Center
HPB
Friday, Mar 22nd
1:58pm – 2:04pm ET
P36: Increased Efficacy of a Synergistic Combination in Sensitizing Pancreatic Neuroendocrine Tumors to Radiation in vivo
Location: C110
Oral Poster Presenter: Jennifer Castle, MD, PhD – University of Kentucky
Submitter: Jennifer Castle, MD, PhD – University of Kentucky
Author: Jennifer Castle, MD, PhD – University of Kentucky
Author: Evelyn Winter da Silva, PhD – University of Kentucky
Author: Aman Chauhan, MD – University of Miami
Author: Percy Ivy, MD – NIH
Author: Susanne Arnold, MD – University of Kentucky
Author: William Carson, III, MD – Ohio State University
Author: B. Mark Evers, MD – University of Kentucky
Author: Jessica Blackburn, PhD – University of Kentucky
Author: Piotr Rychahou, MD – University of Kentucky
Author: Jill Kolesar, PharmD – The University of Kentucky College of Pharmacy
HPB
Friday, Mar 22nd
2:04pm – 2:10pm ET
P37: CA 19-9 Normalization Following Neoadjuvant Therapy and Yield of Laparoscopy for Pancreatic Ductal Adenocarcinoma
Location: C110
Oral Poster Presenter: Brittany C. Fields, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Submitter: Brittany C. Fields, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Brittany C. Fields, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Tim Vreeland, MD – The University of Texas MD Anderson Cancer Center
Author: Tim Newhook, MD – The University of Texas MD Anderson Cancer Center
Author: Rebecca A. Snyder, MD, MPH (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Jess E. Maxwell, MD, MBA (she/her/hers) – The University of Texas MD Anderson Cancer Center
Author: Laura R. Prakash, MD – The University of Texas MD Anderson Cancer Center
Author: Michael P. Kim, MD – The University of Texas MD Anderson Cancer Center
Author: Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center
Author: Jeffrey E. Lee, MD – The University of Texas MD Anderson Cancer Center
Author: Matthew H.G Katz, MD (he/him/his) – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
Author: Ching-Wei D. Tzeng, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
HPB
Friday, Mar 22nd
2:42pm – 2:54pm ET
41: Combination of tumor and CAF subtypes better predict response to neoadjuvant therapy in pancreatic cancer
Location: Georgia Ballroom
Abstract Presenter: Jaewon Lee, MD – University of North Carolina at Chapel Hill
Submitter: Jaewon Lee, MD – University of North Carolina at Chapel Hill
Author: Jaewon Lee, MD – University of North Carolina at Chapel Hill
Author: Joseph Kearney, M.D. – UNC Hospitals- General Surgery
Author: Priscilla Chan, n/a – UNC Chapel Hill
Author: Elena Kharitonova, n/a – University of North Carolina at Chapel Hill
Author: Arthi Hariharan, n/a – University of North Carolina at Chapel Hill
Author: Michelle LaBella, MD – University of North Carolina
Author: Ashley Morrison, n/a – University of North Carolina at Chapel Hill
Author: Ashley Cliff, PhD – University of North Carolina at Chapel Hill
Author: Michael Meyers, MD – University of North Carolina at Chapel Hill
Author: Hong Jin Kim, MD – University of North Carolina at Chapel Hill
Author: Naim Rashid, PhD – University of North Carolina at Chapel Hill
Author: Xianlu Peng, PhD – University of North Carolina at Chapel Hill
Author: Jen Jen Yeh, MD – University of North Carolina at Chapel Hill
HPB
Friday, Mar 22nd
3:30pm – 3:42pm ET
40: Spatial Transcriptomics Reveals Molecular Subtypes of Pancreatobiliary IPMN
Location: Georgia Ballroom
Abstract Presenter: Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan
Submitter: Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan
Author: Matthew K. Iyer, MD/PhD (he/him/his) – University of Michigan
Author: Ashley Fletcher, BS – Duke University Medical Center
Author: Chanjuan Shi, MD, PhD – Duke University
Author: Elishama Kanu, MD – Duke University
Author: Matthew Bao, BS – Duke University
Author: Austin M. Eckhoff, MD – Duke University Medical Center
Author: Daniel P. Nussbaum, MD – Duke University Medical Center
Author: Peter J. Allen, MD – Duke University Medical Center
HPB
Friday, Mar 22nd
4:15pm – 4:45pm ET
Think Tank: Trials in Motion for Colorectal Liver Mets
Location: SSO HUB: HPB, CRS, Upper GI Zone
HUB Moderator: Tim Newhook, MD – The University of Texas MD Anderson Cancer Center
HPBnon-CMEHUB
Saturday, Mar 23rd
8:00am – 9:30am ET
HPB Parallel Session 2
Location: C105-106
Moderator: Carrie Luu, MD – The University of Arizona - Tucson
Moderator: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
HPBCMEOral Abstracts
Saturday, Mar 23rd
8:02am – 8:12am ET
50: Novel Targets in Liver Metastases: Characterizing the Role of CD93 on Liver Sinusoidal Endothelial Cells
Location: C105-106
Abstract Presenter: Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO
Submitter: Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO
Author: Elliott J. Yee, MD (he/him/his) – University of Colorado - Anschutz, CO
Author: Isaac Vigil, BS – University of Colorado - Anschutz, CO
Author: Yi Sun, MD – University of Colorado - Anschutz, CO
Author: Carlton Barnett, MD – University of Colorado - Anschutz, CO
Author: Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery
Author: Yuwen Zhu, PhD – University of Colorado - Anschutz, CO
HPB
Saturday, Mar 23rd
8:12am – 8:22am ET
51: A Chemoresistance Signature to Predict FOLFIRINOX Sensitivity in Pancreatic Adenocarcinoma
Location: C105-106
Abstract Presenter: Zachary Gao, MD – Baylor College of Medicine
Submitter: Zachary Gao, MD – Baylor College of Medicine
Author: Zachary Gao, MD – Baylor College of Medicine
Author: Jiangling Dong, PhD – Baylor College of Medicine
Author: Harinarayanan Janakiraman, PhD – Baylor College of Medicine
Author: Jasmine Choi, BS – Baylor College of Medicine
Author: Derek Erstad, MD – Baylor College of Medicine, Department of Surgery
Author: William Fisher, MD – Baylor College of Medicine, Department of Surgery
Author: George Van Buren, MD – Baylor College of Medicine, Department of Surgery
Author: Sung Wook Kang, PhD – Baylor College of Medicine
Author: Hyun-Sung Lee, MD, PhD – Baylor College of Medicine
Author: E. Ramsay Camp, MD – Baylor College of Medicine
HPB
Saturday, Mar 23rd
8:22am – 8:32am ET
52: Anti-HER-2 Chimeric Antigen Receptor T (CAR-T) Cells Immunotherapy for Pancreatic Cancer: An Innovative Surgically Derived Tumor Spheroid Model
Location: C105-106
Abstract Presenter: ‪lior Orbach, MD (he/him/his) – Surgery Division, Tel Aviv Sourasky Medical Center
Author: ‪lior Orbach, MD (he/him/his) – Surgery Division, Tel Aviv Sourasky Medical Center
Author: Shelly Loewenstein (she/her/hers) – Surgery Division, Tel Aviv Sourasky medical center
Author: Veronika Lerman, n/a – Immunology and Advanced CAR–T based cell therapy Laboratory, Tel-Aviv Sourasky Medical Center.
Author: Daniella Vaskovich, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel-Aviv University
Author: Ron Kleiner, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University
Author: Anat Globerson Levin, n/a – Tel-Aviv Sourasky Medical Center
Author: Ronit Satchi-Fainaro, n/a – Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University
Author: Guy Lahat, n/a (he/him/his) – Tel-Aviv Sourasky Medical Center
HPB
Saturday, Mar 23rd
8:32am – 8:42am ET
53: Preoperative exercise therapy attenuates surgical stress induced liver metastases by inducing Kupffer cell-mediated anti-tumor immunity
Location: C105-106
Abstract Presenter: Susan J. Kim, MD (she/her/hers) – University of Virginia
Submitter: Susan J. Kim, MD (she/her/hers) – University of Virginia
Author: Susan J. Kim, MD (she/her/hers) – University of Virginia
Author: Chengli Shen, MS, PhD – University of Virginia
Author: Yunwei Zhang, MD PhD – University of Virginia
Author: Hongji Zhang, Md PhD – University of Virginia
Author: Allan Tsung, MD – University of Virginia
HPB
Saturday, Mar 23rd
8:42am – 8:52am ET
54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.
Location: C105-106
Abstract Presenter: Emilie A.K Warren, MD – Emory University
Submitter: Emilie A.K Warren, MD – Emory University
Author: Jacklyn N. Hammons, n/a – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
Author: Jessica M. Keilson, MD – Emory University
Author: Guillermo O. Rangel Rivera, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, GA
Author: Megan M. Wyatt, MS – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Author: Caroline R. Goel, MD – Emory University
Author: Curtis J. Henry, PhD – Emory University School of Medicine
Author: Sarah Kulkarni, n/a – Rollins School of Public Health, Emory University
Author: Yuan Liu, PhD, MS – Rollins School of Public Health, Emory University
Author: Brian Robinson, MD, PhD – Emory University School of Medicine
Author: Alyssa M. Krasinskas, MD – Emory University School of Medicine
Author: Nilofer S. Azad, MD (she/her/hers) – Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
Author: Mark Yarchoan, MD – Johns Hopkins Hospital
Author: Shishir K. Maithel, MD, FACS – Winship Cancer Institute of Emory University
Author: Chrystal M. Paulos, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Author: Gregory B. Lesinski, PhD, MPH – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University
HPB
Saturday, Mar 23rd
8:52am – 9:02am ET
55: Autophagy Inhibition Enhances the Maturation and Activity of Tertiary Lymphoid Structures in Patients with Pancreatic Cancer
Location: C105-106
Abstract Presenter: Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center
Submitter: Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Renee R. Anderko, PhD (she/her/hers) – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Annie Walgren, n/a – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Pranav Murthy, MS – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Sarah Bradley, n/a – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Sheryl Kunning, n/a – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Nathan Bahary, MD, PhD – AHN Cancer Institute
Author: Aatur Singhi, MD, PhD – University of Pittsburgh Medical Center
Author: Michael Lotze, MD – University of Pittsburgh, UPMC Hillman Cancer Center
Author: Herbert J. Zeh, III, MD – Department of Surgery, University of Texas Southwestern Medical Center
Author: Amer H. Zureikat, MD – Division of Surgical Oncology, University of Pittsburgh Medical Center
Author: Tullia Bruno, PhD – University of Pittsburgh, UPMC Hillman Cancer Center
HPB
Saturday, Mar 23rd
9:02am – 9:12am ET
56: Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer
Location: C105-106
Abstract Presenter: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
Submitter: Haleh Amirian, MD, MS – University of Miami School of Medicine - Miami, FL
Author: Anna Bianchi, PhD – University of Miami School of Medicine - Miami, FL
Author: Karthik Rajkumar, PhD – University of Miami
Author: Andrew Adam, MS – University of Miami School of Medicine - Miami, FL
Author: Iago De Castro Silva, MD – University of South Florida
Author: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Author: Samara Singh, BS – University of Miami School of Medicine - Miami, FL
Author: Siddharth Mehra, Ph.D. – UM
Author: Erin M. Dickey, MD, MBS – Department of Surgery, University of Miami Miller School of Medicine
Author: Nagaraj Nagathihalli, PhD – University of Miami School of Medicine - Miami, FL
Author: Nipun B. Merchant, MD – Department of Surgery, University of Miami
Author: Jashodeep Datta, MD (he/him/his) – Department of Surgery, University of Miami Sylvester Comprehensive Cancer Center
HPB
Saturday, Mar 23rd
9:12am – 9:22am ET
57: Predicting Local Recurrence of Colorectal Liver Metastasis After Hepatectomy Using Artificial Intelligence
Location: C105-106
Abstract Presenter: Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research
Submitter: Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research
Author: Hardik Y. Patel, D.O. (he/him/his) – The Feinstein Institutes for Medical Research
Author: Matthew Baker, D.O. – Staten Island University Hospital
Author: Joseph Doran, M.D. – Staten Island University Hospital
Author: Gary Deutsch, MD – Northwell Health
Author: Theodoros Zanos, PhD – Feinstein Institutes for Medical Research
HPB